N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide

C29H33N5O6S2 — CID 121045562

IUPACN-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide
SMILESCOc1ccc(S(=O)(=O)Nc2ccc(C(=O)NCCN3CCN(c4nc5c(OC)ccc(OC)c5s4)CC3)cc2)cc1
InChIInChI=1S/C29H33N5O6S2/c1-38-22-8-10-23(11-9-22)42(36,37)32-21-6-4-20(5-7-21)28(35)30-14-15-33-16-18-34(19-17-33)29-31-26-24(39-2)12-13-25(40-3)27(26)41-29/h4-13,32H,14-19H2,1-3H3,(H,30,35)
InChIKeyMJJPEPDGDHBZLA-UHFFFAOYSA-N
MW611.75 g/mol
LogP3.67
Rot. Bonds11

About N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide

N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide (PubChem CID 121045562) has the molecular formula C29H33N5O6S2 and a molecular weight of 611.75 g/mol. Its IUPAC name is N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide.

Molecular Properties

Compound NameN-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide
PubChem CID121045562
Molecular FormulaC29H33N5O6S2
Molecular Weight611.75 g/mol
Exact Mass611.19
IUPAC NameN-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide
SMILESCOc1ccc(S(=O)(=O)Nc2ccc(C(=O)NCCN3CCN(c4nc5c(OC)ccc(OC)c5s4)CC3)cc2)cc1
InChIInChI=1S/C29H33N5O6S2/c1-38-22-8-10-23(11-9-22)42(36,37)32-21-6-4-20(5-7-21)28(35)30-14-15-33-16-18-34(19-17-33)29-31-26-24(39-2)12-13-25(40-3)27(26)41-29/h4-13,32H,14-19H2,1-3H3,(H,30,35)
InChIKeyMJJPEPDGDHBZLA-UHFFFAOYSA-N
XLogP3.67
TPSA122.33 Ų
H-Bond Donors2
H-Bond Acceptors10
Rotatable Bonds11
Heavy Atoms42
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500611.75
LogP ≤ 53.67
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1010

Analyze N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide?
The IUPAC name of N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide (CID 121045562) is N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide.
What is the SMILES notation for N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide?
The canonical SMILES for N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide is COc1ccc(S(=O)(=O)Nc2ccc(C(=O)NCCN3CCN(c4nc5c(OC)ccc(OC)c5s4)CC3)cc2)cc1.
What is the InChIKey of N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide?
The InChIKey is MJJPEPDGDHBZLA-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H33N5O6S2/c1-38-22-8-10-23(11-9-22)42(36,37)32-21-6-4-20(5-7-21)28(35)30-14-15-33-16-18-34(19-17-33)29-31-26-24(39-2)12-13-25(40-3)27(26)41-29/h4-13,32H,14-19H2,1-3H3,(H,30,35).
What are the key properties of N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide?
N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide has a molecular weight of 611.75 g/mol, XLogP of 3.67, 11 rotatable bonds, 2 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-[4-(4,7-dimethoxy-1,3-benzothiazol-2-yl)piperazin-1-yl]ethyl]-4-[(4-methoxyphenyl)sulfonylamino]benzamide is sourced from PubChem (CID 121045562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).